Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome

Clinical trial NCT05302531 · RECRUITING

Trial details

NCT number: NCT05302531
Sponsor: Central Hospital, Nancy, France
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Short Bowel Syndrome Infection, Bacterial

Start date: 2022-12-09
Primary completion: 2024-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.